ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Miss Michelle: Bone to bone

Patient basic information Patient:Michelle Anderson) Nationality: Chongqing Diagnosis: Osteoarthritis Hospital: Chongqing Therapeutic Program: Internal therapy + medication Housing days: 171 days Treatment cost: about 69020 yuan Treatment effect: partial relief The patient is from Chongqing and was diagnosed with Osteoarthritis locally. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on patient inspection reports and physical conditions, and provided translation, escort and on-site services throughout the treatment process. After 171 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached hospital standards.

The treatment effect was a partial relief. When the patient was released, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to monitor the recovery through the remote follow-up system. The patient said: 'We are impressed by the level of expertise of Chinese doctors and the condition of the equipment at Chinese hospitals.

'Mrs. Michelle Liu, this case has been criticized by experts as a typical cross-border clinical case of suspicious seriousness. Li4 Liu relies on a multidisciplinary collaborative mechanism to develop an intracellular treatment + drug program for osteoporosis, reflecting the comprehensive strength of Chinese hospitals in the field of suspicious diagnostics, and a summary of how international medical services are regulated.

(Figure is taken from Li5 Liu's official news report and medical scenario data)

乍得,骨肿瘤,中山大学附属第一医院,国际医疗,来华就医,中国医疗